Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Akush Ginekol (Sofiia) ; 55(6): 10-15, 2016.
Artigo em Búlgaro | MEDLINE | ID: mdl-29370500

RESUMO

The surgical hysteroscopy became popular as a minimally invasive approach to interuterine changes. Dilatation is a real challenge during surgical hyseroscopy especially in first delivery patients, women in menopause and women with cervical stenosis. Apart from this, some long hysteroscopy operations such as myomectomy require adequate dilatation in order to facilitate the multiple insertions and drawing pulling of the resectoscope. Another technical problem is the need for a significant degree of cervical dilatation, as well as softening of the cervix, which will allow the extraction of the excised endometrial polyps or myomatose parts. Mysoprostol is analogous to prostaglandin El, which is commonly used in obstetrics to induce an abortion and birth, as well as after birth to control the excessive vaginal bleeding. Its use in gynecology is limited. In our study it is of vital importance. The vaginal administration of MysoproStol before surgical hysteroscopy facilitates dilatation. The eased hysteroscopy minimizes cervical complications. On the other hand, the natural dilatators Laminaria, made of Laminariajaponica orLaminaria Digitata sticks, are attractive natural substances which can cause dilatation with minimally observed systemic side effects. They have shown efficient results during the cervical preparation before surgical hysteroscopy. Despite of that, there are no comparative studies on the efficiency of the two methods for cervical preparation. The aim of this Study is to compare the efficacy of internally vaginal Mysoprostol against endocervical dilatators Laminaria before surmical hvSterosconv in certain cases.


Assuntos
Produtos Biológicos/uso terapêutico , Colo do Útero/efeitos dos fármacos , Histeroscopia/métodos , Laminaria , Misoprostol/uso terapêutico , Ocitócicos/uso terapêutico , Administração Intravaginal , Adulto , Produtos Biológicos/administração & dosagem , Produtos Biológicos/química , Colo do Útero/cirurgia , Dilatação/métodos , Feminino , Humanos , Laminaria/química , Pessoa de Meia-Idade , Misoprostol/administração & dosagem , Ocitócicos/administração & dosagem , Ocitócicos/química , Gravidez , Adulto Jovem
2.
Akush Ginekol (Sofiia) ; 55(6): 16-18, 2016.
Artigo em Búlgaro | MEDLINE | ID: mdl-29370501

RESUMO

As a representative of the low dose generation of oral contraceptives, Midiana 28 provides minimal intake of estrogens for the female organism in the presence of a new generation getation component- Drospierenone. Midiana has an excellent contraceptive effect - the control group of women showed no cases of impregnation during the intake, Pearl index =0.00. It also exercises a good control over the menstrual cycle with low frequency of intementrual bleeding /17%/ Midiana 28 shows a very good tolerability with minimal, detected, rapidly transient side effects.


Assuntos
Androstenos/farmacologia , Anticoncepcionais Orais Combinados/farmacologia , Estrogênios/farmacologia , Ciclo Menstrual/efeitos dos fármacos , Adolescente , Adulto , Androstenos/administração & dosagem , Androstenos/efeitos adversos , Anticoncepcionais Orais Combinados/administração & dosagem , Anticoncepcionais Orais Combinados/efeitos adversos , Relação Dose-Resposta a Droga , Estrogênios/administração & dosagem , Estrogênios/efeitos adversos , Feminino , Cefaleia/induzido quimicamente , Humanos , Distúrbios Menstruais/induzido quimicamente , Aumento de Peso/efeitos dos fármacos , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA